Evidence map›Paper›PMID 39795518›Full record

ArticlePolymers2025

Exploring the Impact of Structural Modifications of Phenothiazine-Based Novel Compounds for Organic Solar Cells: DFT Investigations.

Walid Taouali, Amel Azazi, Rym Hassani, Entesar H El-Araby, Kamel Alimi

Abstract read
In one paragraph

Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Walid TaoualiResearch Laboratory of Asymmetric Synthesis and Molecular Engineering of Materials for Organic Electronic (LR18ES19), Department of Physics, Faculty of Sciences of Monastir, University of Monastir, Avenue of Environment, Monastir 5019, Tunisia.ORCID 0009-0007-1429-5742
Amel AzaziDepartment of Physical Sciences, Physics Division, College of Science, Jazan University, P.O. Box 114, Jazan 45142, Saudi Arabia.ORCID 0000-0002-9783-3476
Rym HassaniEnvironment and Nature Research Centre, Jazan University, P.O. Box 114, Jazan 45142, Saudi Arabia.ORCID 0000-0002-9340-8835
Entesar H El-ArabyDepartment of Physical Sciences, Physics Division, College of Science, Jazan University, P.O. Box 114, Jazan 45142, Saudi Arabia.
Kamel AlimiResearch Laboratory of Asymmetric Synthesis and Molecular Engineering of Materials for Organic Electronic (LR18ES19), Department of Physics, Faculty of Sciences of Monastir, University of Monastir, Avenue of Environment, Monastir 5019, Tunisia.ORCID 0000-0001-5978-4637

Funding

Deanship of Graduate Studies and Scientific Research, Jazan University, Saudi Arabia RG24-08
6 · The paper itself

Abstract

This paper explores a novel group of D-π-A configurations that has been specifically created for organic solar cell applications. In these material compounds, the phenothiazine, the furan, and two derivatives of the thienyl-fused IC group act as the donor, the π-conjugated spacer, and the end-group acceptors, respectively. We assess the impact of substituents by introducing bromine atoms at two potential substitution sites on each end-group acceptor (EG1 and EG2). With the donor and π-bridge held constant, we have employed density functional theory and time-dependent DFT simulations to explore the photophysical and optoelectronic properties of tailored compounds (M1-M6). We have demonstrated how structural modifications influence the optoelectronic properties of materials for organic solar cells. Moreover, all proposed compounds exhibit a greater V

Indexed as

charge transfer lengthdensity functional theoryopen-circuit voltagereduced density gradienttransition density matrix

Identifiers

PMID39795518
PMCPMC11722700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.